Canaan Inc. Provides Updates to At-the-Market Offering Program
Approximately US$7.8 million raised at an average price of approximately US$1.61 per ADS Company to pause further ATM Sales through 2025 SINGAPORE, Oct. 31, 2025... Read more.
GunsAmerica First Look: Seekins Unveils the SIC Rifle at NASTI
See the original article at GunsAmerica Digest RIGGINS, Idaho, Oct. 31, 2025 /PRNewswire/ — GunsAmerica captured an exclusive first look at Seekins Precision’s... Read more.
Fourvenues Enters the U.S. to Redefine the $100B Nightlife Industry
The go-to platform for iconic venues like Pacha, Bresh, and Zamna brings its all-in-one solution stateside MIAMI, Oct. 31, 2025 /PRNewswire/ — Fourvenues,... Read more.
Spread Your Wings: Applications open tomorrow for seventh edition of the Air Canada and CAE Captain Judy Cameron Scholarship
Eight scholarships available to young Canadian women studying to become commercial pilots or aircraft maintenance engineers Four aspiring commercial pilots will... Read more.
Sanitation Strategies Launches LABSAN PEROXISAN™ TB RTU – A Ready-to-Use Hydrogen Peroxide Disinfectant with 1-Minute Kill on TB and Corynebacterium bovis
HOLT, Mich., Oct. 31, 2025 /PRNewswire/ — Sanitation Strategies, LLC, a leader in innovative sanitation products and services for the biomedical research industry,... Read more.
Kodiak Expands Its Footprint in the Energy Space Through Key Acquisitions of Crown Carbon Reduction Technologies and US Chemical
CINCINNATI, Oct. 31, 2025 /PRNewswire/ — Kodiak announces its seventh and eighth acquisitions since 2023 with the incorporation of Crown Carbon Reduction Technologies... Read more.
Zhimeng Biopharma’s investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ — Shanghai Zhimeng Biopharma Inc. ( “Zhimeng”) announced that its self-developed new-generation potassium... Read more.
AMGEN’S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
Repatha VESALIUS-CV Trial Met Dual Primary Endpoints Demonstrating Reduction in CV Events in High-Risk Patients Who Have Never Had a Heart Attack or Stroke Real-World... Read more.
TXSE Group raises $250 million in capital following second funding round
J.P. Morgan makes strategic investment in the Texas Stock Exchange, joining major global financial institutions, including BlackRock, Charles Schwab, and Citadel... Read more.
IEEE Study Reviews Novel Photonics Breakthroughs of 2024
Researchers focus on their pathbreaking study on coupling free electrons with nonlinear optical states in integrated photonic microresonators NEW YORK, Oct. 31,... Read more.